Strawberry Consumption in Overweight and Obese Individuals

Last updated: August 25, 2025
Sponsor: Carl Ade, M.S., Ph.D.
Overall Status: Completed

Phase

N/A

Condition

Obesity

High Cholesterol (Hyperlipidemia)

Diabetes Prevention

Treatment

Active strawberry powder

Placebo strawberry powder

Mixed strawberry powder

Clinical Study ID

NCT04094103
Pro9736
  • Ages 35-75
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Our proposal represents an integrated approach to determining the cardiovascular and metabolic effects of strawberry consumption in adults who have high risk for cardiometabolic disease.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Overweight or obese by BMI (25.0-34.9kg/m2),

  • Borderline-high LDL-cholesterol (130-159mg/dL),

  • Normal or elevated blood pressure ((≤129mmHg/≤80mmHg)

Exclusion

Exclusion Criteria:

  • known allergy or intolerance to strawberries

  • taking any medications for chronic diseases including anti-inflammatory,anti-hypertensive, lipid-lowering, glucose-controlling, or steroidal medications

  • taking any supplements that might affect outcomes of the study includinganti-oxidant or fish-oil supplements

  • having anemia or any liver, thyroid, renal conditions

  • current smoker or user of tobacco products, or use within the past three months

  • consuming alcohol (>1-2 drinks/day) on a regular basis

  • currently pregnant or lactating

  • having elevated blood pressure ≥130mmHg/≥80mmHg

  • presence of diagnosed diabetes mellitus, inflammatory disease, atheroscleroticdisease, or other relevant chronic conditions

  • total cholesterol ≥240mg/dL

  • hemoglobin normal range values for males (between 13.0-17.5g/dL) and females (between 12.5-15.5g/dL)

Study Design

Total Participants: 48
Treatment Group(s): 3
Primary Treatment: Active strawberry powder
Phase:
Study Start date:
October 01, 2019
Estimated Completion Date:
October 27, 2023

Study Description

The current proposal aims to fill some of these important research gaps with regard the dose and time-course of strawberry consumption in a population where dietary intervention may of particular benefit for both primary and secondary prevention of cardiovascular and metabolic disease. Participants will participate in a double blind, placebo-controlled, randomized crossover trial. Following a 10-day run-in where no berries are consumed, participants will be randomized via Latin-square design, to three different daily strawberry powder conditions for 4-weeks at a time, with a 7 day washout between conditions.

Connect with a study center

  • Lafene Health Center

    Manhattan, Kansas 66502
    United States

    Site Not Available

  • Lafene Health Center

    Manhattan 4274994, Kansas 4273857 66502
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.